The UK Parliamentary Office of Science and Technology has published a briefing on the need for greater transparency in clinical trials. The document is targeted at Members of Parliament but it’s a good background reading for everyone on the need for registration of clinical trials, how that can be accomplished and some of the potential challenges. Read the briefing at the POST website.
The UK medicines regulator destroys detailed information on the benefits and harms of medicines it has approved after it has held it for 15 years. This means that for medicines which have been on the market for longer than 15 years, which is the majority of them, the Medicines and Healthcare Products Regulatory Agency (MHRA) […]